AMN

SEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001142750-24-000007 · wk-form4_1705531800.xml · derivative · entry 5

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,315

Underlying: Common Stock · 32,315 shares

Expires not disclosed

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock

F6 · derivative.exercise_date: The Restricted Stock Units in this row were granted on January 15, 2024 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-24-000007 · wk-form4_1705531800.xml · derivative · entry 4

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,935

Underlying: Common Stock · 4,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-24-000007 · wk-form4_1705531800.xml · nonDerivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,678

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-24-000007 · wk-form4_1705531800.xml · nonDerivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001142750-24-000006 · wk-form4_1704820457.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,024

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-24-000006 · wk-form4_1704820457.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,472

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2021. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2023 for the 3-year period beginning on January 1, 2021 and ended December 31, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2023. The Company's Relative TSR measured in the 55th percentile and its absolute total shareholder return for the period was positive. Based on these results, 115% of the PRSUs for this award were deemed earned and vested.

SEC source: 0001142750-24-000005 · wk-form4_1704820179.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,053

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-24-000005 · wk-form4_1704820179.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,168

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2021. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2023 for the 3-year period beginning on January 1, 2021 and ended December 31, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2023. The Company's Relative TSR measured in the 55th percentile and its absolute total shareholder return for the period was positive. Based on these results, 115% of the PRSUs for this award were deemed earned and vested.

SEC source: 0001142750-24-000003 · wk-form4_1704753905.xml · derivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,354 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-24-000003 · wk-form4_1704753905.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,415

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-24-000003 · wk-form4_1704753905.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001142750-24-000002 · wk-form4_1704753812.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 225 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-24-000002 · wk-form4_1704753812.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,782

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-24-000002 · wk-form4_1704753812.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · derivative · entry 6

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,470

Underlying: Common Stock · 2,694 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · derivative · entry 5

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,941

Underlying: Common Stock · 5,388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · nonDerivative · entry 4

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,114

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · nonDerivative · entry 3

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · nonDerivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,076

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-23-000034 · wk-form4_1701363362.xml · nonDerivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001142750-23-000032 · wk-form4_1701363268.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,018

SEC source: 0001142750-23-000027 · wk-form4_1699037738.xml · derivative · entry 3

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,950

Underlying: Common Stock · 9,656 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on November 2, 2021 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001142750-23-000027 · wk-form4_1699037738.xml · nonDerivative · entry 2

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,330

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001142750-23-000027 · wk-form4_1699037738.xml · nonDerivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-052983 · doc4.xml · derivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,766

Underlying: Common Stock · 6,766 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on October 15, 2023 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-052560 · doc4.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,276 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 7, 2020 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-052560 · doc4.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,624

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-052560 · doc4.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-049831 · doc4.xml · derivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,463

Underlying: Common Stock · 1,463 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-046580 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,648

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-046580 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,693

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2023. The Company's Relative TSR measured in the 75th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-046577 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,018

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-046577 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,658

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2023. The Company's Relative TSR measured in the 75th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-037843 · doc4.xml · nonDerivative · entry 2

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 7,799

F4 · price: The price reported in this row represents a weighted average price of $110.25 per share. These shares were sold in multiple transactions at prices ranging from $110.23 to $110.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: The number of shares reflected in this column does not include 2,139 vested RSUs that the Reporting Person elected to defer at the time of grant until her retirement from the Board of Directors.

F3 · ownership.nature: These shares are held in the Daphne E. Jones Revocable Trust, of which the Reporting Person is the sole trustee and the sole beneficiary.

SEC source: 0001209191-23-037843 · doc4.xml · nonDerivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 8,008

F1 · price: The price reported in this row represents a weighted average price of $109.39 per share. These shares were sold in multiple transactions at prices ranging from $109.08 to $109.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: The number of shares reflected in this column does not include 2,139 vested RSUs that the Reporting Person elected to defer at the time of grant until her retirement from the Board of Directors.

F3 · ownership.nature: These shares are held in the Daphne E. Jones Revocable Trust, of which the Reporting Person is the sole trustee and the sole beneficiary.

SEC source: 0001209191-23-031172 · doc4.xml · derivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031171 · doc4.xml · derivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031169 · doc4.xml · derivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031167 · doc4.xml · derivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031163 · doc4.xml · derivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031165 · doc4.xml · derivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031160 · doc4.xml · derivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-031152 · doc4.xml · derivative · entry 1

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common Stock · 1,681 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-029228 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,318

F1 · kind: The reporting person transferred 200 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-23-025611 · doc4.xml · derivative · entry 2

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-025611 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-23-025610 · doc4.xml · derivative · entry 2

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-23-025610 · doc4.xml · nonDerivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,597

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-23-025609 · doc4.xml · derivative · entry 2

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.